In current study, this is the first case – control study was carried out to evaluate whether or not LMP-1, LMP-2 expression could be further applied in NPC screening, diagnosis as well as therapy in Vietnam. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.